Glen Moller Net Worth

The estimated Net Worth of Glen Moller is at least $3.63 mil dollars as of 28 January 2020. Glen Moller owns over 1,846 units of DarioHealth Corp stock worth over $3,634 and over the last 6 years Glen sold DRIO stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Glen Moller DRIO stock SEC Form 4 insiders trading

Glen has made over 4 trades of the DarioHealth Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently Glen bought 1,846 units of DRIO stock worth $1,458 on 28 January 2020.

The largest trade Glen's ever made was buying 20,832 units of DarioHealth Corp stock on 9 July 2019 worth over $16,457. On average, Glen trades about 5,872 units every 73 days since 2019. As of 28 January 2020 Glen still owns at least 4,600 units of DarioHealth Corp stock.

You can see the complete history of Glen Moller stock trades at the bottom of the page.

What's Glen Moller's mailing address?

Glen's mailing address filed with the SEC is 8 HATOKHEN STREET, , CAESAREA INDUSTRIAL PARK, L3, 3088900.

Insiders trading at DarioHealth Corp

Over the last 9 years, insiders at DarioHealth Corp have traded over $4,057,564 worth of DarioHealth Corp stock and bought 2,163,162 units worth $794,618 . The most active insiders traders include Erez Raphael, Adam K Stern y Yoav Shaked. On average, DarioHealth Corp executives and independent directors trade stock every 33 days with the average trade being worth of $20,360. The most recent stock trade was executed by Steven Charles Nelson on 5 September 2024, trading 15,000 units of DRIO stock currently worth $12,300.

What does DarioHealth Corp do?

DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.

Complete history of Glen Moller stock trades at DarioHealth Corp

DarioHealth Corp executives and stock owners

DarioHealth Corp executives and other stock owners filed with the SEC include:

• Erez Raphael,
  Chief Executive Officer, Director
• Erez Raphael,
  CEO & Director
• Richard A. Anderson,
  Pres & GM of North America
• Dror Bacher,
  Chief Operating Officer
• Zvi Ben-David,
  Chief Financial Officer, Treasurer, Secretary
• Olivier Jarry,
  Senior Vice President - Strategy and Business Development
• Dror Bacher,
  Chief Operating Officer
• Zvi Ben David,
  CFO, Treasurer & Sec.
• Richard Stone,
  Independent Director
• Dennis McGrath,
  Independent Director
• Hila Karah,
  Independent Director
• Dennis Matheis,
  Director
• Omar Manejwala,
  Chief Medical Officer
• Barbara Stark,
  Senior Vice President, Head of Managed Markets
• Adam Stern,
  Director
• Yadin Shemmer,
  Independent Director
• Richard Anderson,
  President, General Manager - North America
• Allen Kamer,
  Independent Director
• Yoav Shaked,
  Independent Chairman of the Board
• Limor Drezner,
  VP HR & Chief of Staff
• Josh Fischer,
  Sr. VP of Operations & Compliance
• Yinon Amir,
  Head of Software Innovation
• Jean Christophe Muyl,
  Head of Commercialization North America
• Suzanne Bedell,
  VP of Marketing
• Claudia Levi,
  Content & Communications Mang.
• Dov Oppenheim,
  Co-Founder & Production Chief
• Olivier R. Jarry,
  Sr. VP of Strategy & Bus. Devel.
• Hod Rami Yehudiha,
  Director
• Glen Moller,
  Director
• Yalon Farhi,
  Director
• Malcolm Hoenlein,
  Director
• Ori Zanco,
  Director
• Yossi Bahagon,
  Director
• Shmuel Farhi,
  10% owner
• Yossef Balucka,
  CEO and President
• Oded Cohen,
  GM MSK
• Jon H. Kaplan,
  Director
• Tomer Ben Kiki,
  Chief Operating Officer
• Steven Charles Nelson,
  Chief Commercial Officer